Propafenone

CAS No. 54063-53-5

Propafenone( —— )

Catalog No. M14930 CAS No. 54063-53-5

An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 34 In Stock
10MG 45 In Stock
25MG 61 In Stock
50MG 98 In Stock
100MG 129 In Stock
200MG 181 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Propafenone
  • Note
    Research use only, not for human use.
  • Brief Description
    An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
  • Description
    An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
  • In Vitro
    Propafenone (5-25 μM) inhibits esophageal squamous cell carcinoma (ESCC) cell proliferation.Propafenone causes mitochondrial dysfunction by a decreased mitochondrial membrane potential and reduced expression of Bcl-xL and Bcl-2. Propafenone (10 and 20 μm) treatment significantly down regulates the expression levels of the anti-apoptotic proteins Bcl-xL and Bcl-2 in ESCC cells. Propafenone also reduces expression of p-ERK. Cell Proliferation Assay Cell Line:The human ESCC cell lines KYSE30, KYSE150 and KYSE270 Concentration:5, 10, 15, 20, and 25 μm Incubation Time:24, 48, and 72 hours Result:Gradually decreased cell proliferation over time and potently inhibited cell proliferation with increasing concentrations in KYSE30, KYSE150 and KYSE270 cells.Western Blot Analysis Cell Line:The human ESCC cell lines KYSE30, KYSE150 and KYSE270 Concentration:0, 10, and 20 μm Incubation Time:72 hours Result:Significant downregulation of Bcl-xL and Bcl-2 expression levels was observed.
  • In Vivo
    Propafenone (20 mg/kg; intraperitoneal injection every other day) markedly suppresses the tumor burden with a decrease of 69.2%.Propafenone also significantly inhibits tumor cell proliferation (mean index decreased from 56.3±6.7% in the DMSO-treated group to 20.7±5.1% in the 10 mg/kg propafenone-treated group and 11.3±4.0% in the 20 mg/kg propafenone-treated group). Animal Model:Female BALB/c nude mice bearing KYSE270-derived xenografts (6-8 weeks)Dosage:10 mg/kg or 20 mg/kg Administration:Intraperitoneally injected Result:Exerted a significantly inhibitory effect on the growth of tumor xenografts.
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    MRP
  • Recptor
    MRP1| Potassium Channel| Sodium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    54063-53-5
  • Formula Weight
    341.44
  • Molecular Formula
    C21H27NO3
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 93.28 mg/L
  • SMILES
    CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Overington JP, et al. Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
molnova catalog
related products
  • Reserpine

    Reserpine (Serpalan) is an indole alkaloid antipsychotic and antihypertensive drug that irreversibly blocks the vesicular monoamine transporter (VMAT).

  • PU23

    PU 23 is an inhibitor of multidrug-resistant protein 4 (MRP4).

  • Perindopril erbumine

    PERINDOPRIL ERBUMINE is an angiotensin-converting enzyme inhibitor.